BOSTON, MA — Riverside Partners, a leading private equity firm focused on investing in middle market healthcare and technology companies, today announced the addition of medical device and diagnostic industry veteran, Dr. Michael Magliochetti, as an Operating Partner.
Dr. Magliochetti brings over 20 years of successful healthcare operating and acquisition experience to Riverside. Dr. Magliochetti most recently served as the CEO of Claros Diagnostics, a point-of-care in-vitro diagnostic firm, which was honored as one of the Top 50 Most Innovative Companies in the World for 2011 by MIT Technology Review, and acquired by OPKO Health. He previously served as CEO of RMH, Inc., a leading orthopedics company, which was acquired, and as the CEO of both HemaMetrics Corporation and UroSurge Corporation. He has held senior positions with the medical device company Haemonetics Corporation; the polymer products company Delta Surprenant, and has completed an assignment with the U.S. Army Research Command. In addition to serving on Advisory Boards for Boston Children's Hospital and Lahey Clinic, Dr. Magliochetti has also served as an Adjunct Professor of Biomedical Engineering at the University of Iowa and consulted with several medical device and pharmaceutical companies.
Dr. Magliochetti holds B.S. and Ph.D. degrees in Chemical Engineering from Northeastern University and the University of Massachusetts at Amherst, respectively, and a High Technology M.B.A. from Northeastern University. “Riverside came to know Mike over the last several years through his participation in our Healthcare Advisory Board and his service on the Tegra Medical board of directors,” said Philip Borden, General Partner at Riverside Partners. “Mike brings both a depth and a breadth of healthcare experience to Riverside that will strengthen our overall efforts in healthcare investing. Furthermore, Mike will continue Riverside's tradition of relying on Operating Partners to add post-investment operational value to our portfolio companies.”
About Riverside Partners
Founded in 1989, Riverside Partners is a middle market private equity firm focusing on growth-oriented companies in the healthcare and technology industries. Riverside is particularly experienced at partnering with founders, owners and management teams and it brings substantial domain expertise and operating experience to its portfolio companies. The partners at Riverside have managed more than $700 million in investments in over 60 companies. The firm is currently focused on companies with revenues between $20-$200 million and with $5-$25 million of EBITDA. For more information, please visit www.riversidepartners.com
Riverside Partners
Jon Lemelman
General Partner
Riverside Partners, LLC
One Exeter Plaza
699 Boylston St., 14th floor
Boston, MA 02116
Tel (Direct): 617 351 2810
jlemelman@riversidepartners.com
Copyright 2009, Riverside Partners, LLC.